Ari Maizel
Chief Commercial Officer · 4 filings · Latest: Apr 22, 2026
Axsome Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AXSM | Ari Maizel | Chief Commercial Officer | Apr 22, 2026 | Sale | $182.42 | 7,500 | $1.4M | 0 | |
AXSM | Ari Maizel | Chief Commercial Officer | Apr 22, 2026 | Option Exercise | $70.73 | 7,500 | $530.5K | 7,500 | |
AXSM | Maizel Ari | — | Apr 22, 2026 | Proposed Sale | $182.42 | 7,500 | $1.4M | — | |
AXSM | Ari Maizel | Chief Commercial Officer | Jan 21, 2026 | Sale | $184.44 | 7,500 | $1.4M | 0 | |
AXSM | Ari Maizel | Chief Commercial Officer | Jan 21, 2026 | Option Exercise | $70.73 | 7,500 | $530.5K | 7,500 | |
AXSM | Maizel Ari | — | Jan 21, 2026 | Proposed Sale | $184.44 | 7,500 | $1.4M | — |